Michael J. McGinley, Presi, Biologic. & Pharm at HESKA CORP (HSKA), sold 5,998 shares at $36.50 ($219K) on 2016-05-10, disclosed to the SEC on 2016-05-10.
Open-market sale of $219k HSKA by Presi, Biologic. & Pharm. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.50 | 634 | $23K | 10.6% |
| 2 | $36.50 | 1,560 | $57K | 26.0% |
| 3 | $36.50 | 3,804 | $139K | 63.4% |
| Total | $36.50 avg | 5,998 | $219K | 100% |
| Filing → |
| HSKA | SELL | 2017-06-01 | $2.2M | — | Filing → |
| HSKA | SELL | 2016-11-09 | $729K | — | Filing → |
| HSKA | SELL | 2015-11-25 | $48K | — | Filing → |